Principal Scientist - Predictive Molecule Design
Bristol Myers Squibb
Summary
Computational Sciences is seeking an exceptional Principal Scientist to join our Small Molecule Computational Design team. Using computational chemistry, cheminformatics, and machine learning, you will work as a member of our multidisciplinary project teams to proactively generate and test scientific hypotheses and directly translate those into actionable molecular designs that meaningfully advance our discovery programs.
Job description
Position Summary
Computational Sciences is seeking an exceptional Principal Scientist to join our Small Molecule Computational Design team. Using computational chemistry, cheminformatics, and machine learning, you will work as a member of our multidisciplinary project teams to proactively generate and test scientific hypotheses and directly translate those into actionable molecular designs that meaningfully advance our discovery programs.
What You'll Do
- Serve independently as the computational scientist on Small Molecule project teams, bringing both structure-based and data-driven approaches to bear on the same problem, and holding accountability for delivery of the computational objectives of those programs.
- Design, prioritize, and triage chemical matter, applying multi-parameter optimization to advance potency, selectivity, and ADME properties, while proactively identifying and mitigating potential toxicological risks.
- Develop, validate, and deploy predictive models and cheminformatics workflows and drive their adoption by project teams as routine decision-making tools rather than one-off analyses.
- Integrate structural information from co-crystal structures, cryo-EM, and predicted or modeled structures with large-scale data analysis and visualization to deepen structure-activity relationship insight and shape project strategy.
- Curate and steward the chemical and biological data resources, reusable tooling, and analysis infrastructure that the group depends on, ensuring analyses are reproducible, discoverable, and useful to scientists beyond their original author.
- Provide scientific leadership within Computational Sciences and our close partners on emerging technologies, platforms, targets, etc., taking calculated risk to test and advance innovative approaches within the group and among stakeholders.
- Act as an active mentor to colleagues, serve as a recognized internal subject area resource, and grow internal and external scientific visibility through publications, presentations, and patent applications.
What We're Looking For
- Ph.D. with 4+ years of academic or industry experience, Master's degree with 6+ years of experience, Bachelor's degree with 8+ years of experience in computational chemistry, cheminformatics, computational biophysics, chemistry, or a related discipline.
- Strong history of directly impacting small molecule discovery programs in biotech or pharmaceutical industry, with a solid working knowledge of medicinal chemistry principles.
- Demonstrated hands-on depth across both computer-aided drug design and cheminformatics/machine learning. This dual capability is the defining requirement of the role.
- Experience applying computational modeling, AI/ML, data analytics, and optimization methods to advance drug discovery programs.
- Demonstrated experience applying computational methods to a variety of biological targets (e.g., proteins, DNA, RNA) and familiarity with diverse therapeutic modalities such as covalent and non-covalent inhibitors, allosteric modulators, targeted protein degraders, antibodies, and antibody-drug conjugates.
- Superior communication skills and a collaborative mindset that thrives in multidisciplinary and geographically dispersed project teams.
- Track record of publications in peer-reviewed scientific journals.
Requirements
- Ph.D. with 4+ years of academic or industry experience, Master's degree with 6+ years of experience, or Bachelor's degree with 8+ years of experience in computational chemistry, cheminformatics, computational biophysics, chemistry, or a related discipline
- Strong history of directly impacting small molecule discovery programs in biotech or pharmaceutical industry
- Solid working knowledge of medicinal chemistry principles
- Demonstrated hands-on depth across both computer-aided drug design and cheminformatics/machine learning
- Experience applying computational modeling, AI/ML, data analytics, and optimization methods to advance drug discovery programs
- Demonstrated experience applying computational methods to a variety of biological targets (e.g., proteins, DNA, RNA)
- Familiarity with diverse therapeutic modalities such as covalent and non-covalent inhibitors, allosteric modulators, targeted protein degraders, antibodies, and antibody-drug conjugates
- Superior communication skills and a collaborative mindset
- Track record of publications in peer-reviewed scientific journals
Benefits
- Medical, Dental & Vision
- Life & Disability Insurance
- Retirement Benefits
- Flexible Time Off
- 11 Paid Holidays
- Paid Sick Leave
- Volunteer Days
- Summer Hours Flexibility
- Global Shutdown
- Incentive Cash & Stock
Company overview
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Founded in 1887 and headquartered in Princeton, New Jersey, the company operates with a unique BioPharma strategy that combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility of a biotech firm. BMS focuses on transformative therapies in key therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and fibrosis. The company has built a sustainable pipeline of potential therapies and leverages translational medicine and data analytics to deliver the right medicine to the right patient at the right time. With over 10,000 employees worldwide, Bristol Myers Squibb maintains a strong commitment to scientific excellence, patient-centric innovation, and global health equity through its foundation. The company's portfolio includes groundbreaking treatments such as Opdivo (nivolumab) for cancer, Eliquis (apixaban) for cardiovascular conditions, and Orencia (abatacept) for autoimmune diseases, among others.